Structures by: Mei W.
Total: 9
C26H24N2O2
C26H24N2O2
Journal of medicinal chemistry (2018) 61, 23 10488-10501
a=10.2122(13)Å b=16.083(2)Å c=12.5447(16)Å
α=90.00° β=104.737(2)° γ=90.00°
P21/c
0.44(C27H26N2O2)
Journal of medicinal chemistry (2018) 61, 23 10488-10501
a=12.2700(3)Å b=21.5852(4)Å c=8.2015(3)Å
α=90° β=99.774(3)° γ=90°
C26H23N3O3
C26H23N3O3
Journal of medicinal chemistry (2018) 61, 23 10488-10501
a=7.738(6)Å b=10.534(8)Å c=14.044(10)Å
α=70.163(8)° β=86.367(9)° γ=81.901(8)°
C27H18ClN5O2.25Ru
C27H18ClN5O2.25Ru
Metallomics : integrated biometal science (2014) 6, 12 2204-2212
a=27.1414(5)Å b=27.1414(5)Å c=7.5825(4)Å
α=90.00° β=90.00° γ=90.00°
C26H27Cl2N4O4Ru
C26H27Cl2N4O4Ru
MedChemComm (2014) 5, 5 597
a=16.2535(11)Å b=7.7798(4)Å c=22.0549(14)Å
α=90.00° β=107.949(8)° γ=90.00°
C26H20ClN4ORu,6(H2O),Cl
C26H20ClN4ORu,6(H2O),Cl
Dalton transactions (Cambridge, England : 2003) (2014) 43, 24 9216-9225
a=7.6148(10)Å b=12.5489(18)Å c=15.8363(18)Å
α=87.621(10)° β=82.199(10)° γ=77.590(12)°
C27H22ClN4ORu,Cl,4(H2O)
C27H22ClN4ORu,Cl,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 24 9216-9225
a=12.0937(10)Å b=7.7505(4)Å c=30.5757(13)Å
α=90.00° β=93.219(6)° γ=90.00°
C25H23BrCl2N4O3Ru
C25H23BrCl2N4O3Ru
Organometallics (2016) 35, 317-326
a=42.491(9)Å b=17.479(4)Å c=7.6315(15)Å
α=90.00° β=90.10(3)° γ=90.00°
C25H23Cl3N4O3Ru
C25H23Cl3N4O3Ru
Organometallics (2016) 35, 317-326
a=42.2839(12)Å b=17.4919(7)Å c=7.5827(2)Å
α=90.00° β=90.996(3)° γ=90.00°